Neuroone Medical Technologies (NMTC) Non-Current Debt (2010 - 2019)

Neuroone Medical Technologies (NMTC) reported Non-Current Debt of $528000.0 for Q3 2019, little changed sequentially from $528000.0 in Q2 2019.

Neuroone Medical Technologies (NMTC) Non-Current Debt (2010 - 2019) Analysis & Trends

Neuroone Medical Technologies has disclosed Non-Current Debt across 5 years of filings, most recently posting $528000.0 for Q3 2019.

Quarterly Non-Current Debt changed N/A year-over-year to $528000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $528000.0 (changed N/A YoY) and the FY2019 annual result came in at $528000.0, changed N/A from the prior year.
Non-Current Debt was little changed at $528000.0 in Q3 2019, from $528000.0 in the prior quarter.
Across five years, Non-Current Debt topped out at $1.8 million in Q2 2018 and bottomed at $528000.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	29.64 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.22 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.81 Bn
10	Neuroone Medical Technologies	26.73 Mn	23.93 Mn	990,264.00	-

Download Data